31085-55-9

Basic information

• Product Name: N,5'-O-Ditrityladenosine
• Synonyms: N-(Triphenylmethyl)-5'-O-(triphenylmethyl)adenosine;N,5'-O-Bis(triphenylmethyl)adenosine;N,5'-O-Ditrityladenosine;(2R,3R,4S,5R)-2-(6-(tritylamino)-9H-purin-9-yl)-5-((trityloxy)methyl)tetrahydrofuran-3,4-diol(WX191896);(2R,3R,4S,5R)-2-(6-(tritylamino)-9H-purin-9-yl)-5-((trityloxy)methyl)tetrahydrofuran-3,4-diol
• CAS NO: 31085-55-9
• Molecular Formula: C₄₈H₄₁N₅O₄
• Molecular Weight: 751.87
• Mol File: 31085-55-9.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Density: 1.26g/cm³
• Refractive Index: 1.672
• CAS DataBase Reference: N,5'-O-Ditrityladenosine(CAS DataBase Reference)
• NIST Chemistry Reference: N,5'-O-Ditrityladenosine(31085-55-9)
• EPA Substance Registry System: N,5'-O-Ditrityladenosine(31085-55-9)

Safety Data

• Hazardous Substances Data: 31085-55-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C48H41N5O4/c54-42-40(31-56-48(37-25-13-4-14-26-37,38-27-15-5-16-28-38)39-29-17-6-18-30-39)57-46(43(42)55)53-33-51-41-44(49-32-50-45(41)53)52-47(34-19-7-1-8-20-34,35-21-9-2-10-22-35)36-23-11-3-12-24-36/h1-30,32-33,40,42-43,46,54-55H,31H2,(H,49,50,52)

Upstream product

• 110-86-1 pyridine 
• 76-83-5 trityl chloride 
• 58-61-7 adenosine 

Downstream Products

• 81069-19-4 (2E,7E)-5-oxa-4-(tritylamino-9-purinyl)-6-trityloxymethylnona-2,7-dienedinitrile 
• 81069-20-7 (2Z,7E)-5-oxa-4-(6-tritylamino-9-purinyl)-6-trityyloxymethylnona-2,7-dienedioate de diethyle 
• 81069-20-7 (2E,7E)-5-oxa-4-(6-tritylamino-9-purinyl)-6-trityyloxymethylnona-2,7-dienedioate de diethyle 
• 101072-38-2 2',3'-O-Methylene-5'-O,6-N-bisadenosine 
• 135216-47-6 5'-O,N⁶-bis(triphenylmethyl)-2',3'-secoadenosine 
• 58-61-7 adenosine 
• 426818-71-5 N⁶,5'-O-ditrityladenosine-2',3'-cyclic sulfate 
• 948048-03-1 2',3'-di-O-trifluoromethylsulfonyl-6-N,5'-O-ditrityladenosine 
• 946497-19-4 2',3'-dideoxy-2'-fluoro-3'-(O-methyltyrosyl)aminoadenosine 
• 948048-18-8 9-(2'-azido-2'-deoxy-6-N,5'-O-ditrityl-β-D-arabinofuranosyl)adenine 
• 948048-06-4 3'-azido-2',3'-dideoxy-2'-fluoro-6-N,5'-O-ditrityladenosine 
• 948048-20-2 2'-azido-2',3'-dideoxy-3'-fluoro-6-N,5'-O-ditrityladenosine 
• 948048-07-5 3'-[(2-N-tert-butoxycarbonyl-O-methyl)-L-tyrosyl]amido-2',3'-dideoxy-2'-fluoro-6-N,5'-O-ditrityladenosine 

Relevant articles and documents

COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1

The disclosure provides compositions and methods related to activating alpha-kinase 1 (ALPK1) for modulating an immune response and treating or preventing cancer, infection, inflammation and related diseases and disorders as well as potentiating an immune response to a target antigen. The disclosure also provides heterocyclic compounds of formula (I) as agonists of alpha protein kinase 1 (ALPK1) and their use in activating ALPK1, modulating an immune response and treating diseases such as cancer, wherein A1, A2, L1, L2, L3, Z1, Z2, W1, W2, R1, R2, R3, R4, R5, R6 and R7 are defined herein.

CYCLIC DINUCLEOTIDES AS STING AGONISTS

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R, R1B, R1C, R2B

First synthesis of 2'-deoxyfluoropuromycin analogues: Experimental insight into the mechanism of the staudinger reaction

The N6, N6-dedimethyl-2'-deoxyfluoro analogue of puromycin (= 3'-deoxy-N6, N6-dimethyl-3'- [Omethyltyrosylamido]adenosine), its 2',3'-regioisomer and a 3'-cytidyl-5'-(2'deoxyfluoro)puromycyl dinucleotide analogu